Stoky
Back to explore
N
NoahListening
A
AshListening
0:00 / 0:00I. Business Overview and Strategic Initiatives
BDX logo

BD Achieves 8.2% Revenue Growth Amid $4 Billion Strategic Acquisition and Portfolio Reshaping

BDX10-KFiling Date: 11/25/2025
Becton, Dickinson and Company
Description

What this story covers

Noah and Ash discuss Becton Dickinson’s fiscal 2025 performance, highlighting its 8.2% revenue growth, the $3.9 billion acquisition of Advanced Patient Monitoring, and strategic restructuring to focus on "smart" connected care despite $1.8 billion in legal reserves.

Story snapshot

CompanyBecton, Dickinson and Company
TickerBDX
VariantStandard detailed
Duration20:08
Filing type10-K
PeriodAnnual 2025
IndustryHealthcare & Pharmaceuticals
Accession0000010795-25-000099
Sources1

Full Story Script

Content not available for this story.

Primary Sources

sec_filing10-KView on SEC.gov →

Ask Noah

Question the story, source filings, and key financial signals.

Sign in to chat with Noah

Ask questions about revenue, margins, risk factors, filings and more. Noah uses retrieval-augmented analysis over raw financial disclosures.

Sign in